Adams, Jessica M <br/><br/>
Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons.  [electronic resource] 

 -  Diabetes  08 2018 
 - 1538-1548 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1939-327X 
<br/><br/><label>Standard No.: </label>10.2337/db17-1385  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Appetite Depressants--therapeutic use<br/>Diet, High-Fat--adverse effects<br/>Energy Intake--drug effects<br/>GABAergic Neurons--drug effects<br/>Genes, Reporter--drug effects<br/>Glucagon-Like Peptide-1 Receptor--chemistry<br/>Green Fluorescent Proteins--chemistry<br/>Hypoglycemic Agents--therapeutic use<br/>Hypothalamus--drug effects<br/>Liraglutide--therapeutic use<br/>Male<br/>Mice, Knockout<br/>Mice, Transgenic<br/>Nerve Net--drug effects<br/>Nerve Tissue Proteins--agonists<br/>Neurons--drug effects<br/>Obesity--drug therapy<br/>Random Allocation<br/>Recombinant Fusion Proteins--chemistry<br/>Vesicular Glutamate Transport Protein 2--chemistry<br/>Vesicular Inhibitory Amino Acid Transport Proteins--chemistry<br/>Weight Loss--drug effects<br/>Glucagon-Like Peptide-1 Receptor Agonists